THE SICILIAN NETWORK OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY DATA FROM A PROSPECTIVE STUDY ON EFFICACY AND SAFETY

被引：0

作者：

Orlando, A. ^{[1
]}

Fries, W. ^{[2
]}

Privitera, A. ^{[20
]}

Cappello, M. ^{[3
]}

Siringo, S. ^{[4
]}

Inserra, G. ^{[5
]}

Magnano, A. ^{[6
]}

Di Mitri, R. ^{[7
]}

Belluardo, N. ^{[8
]}

Scarpulla, G. ^{[9
]}

Magri, G. ^{[10
]}

Trovatello, A. ^{[11
]}

Carroccio, A. ^{[12
]}

Genova, S. ^{[13
]}

Calandruccio, G. ^{[14
]}

Vassallo, R. ^{[15
]}

Romano, C. ^{[16
]}

Magazzu, G. ^{[17
]}

Citrano, M. ^{[18
]}

Accomando, S. ^{[19
]}

Ventimiglia, M. ^{[1
]}

Renna, S. ^{[1
]}

Orlando, R. ^{[1
]}

Rizzuto, G. ^{[1
]}

Vinci, E. ^{[1
]}

Macaluso, F. S. ^{[1
]}

Cottone, M. ^{[1
]}

机构：

[1] Villa Sofia Cervello Hosp, Div Internal Med, Palermo, Italy

[2] AOU Policlin G Martino, Inflammatory Bowel Dis Unit, Messina, Italy

[3] AOU Policlin G Giaccone, Gastroenterol & Hepatol Unit, Palermo, Italy

[4] ARNAS Garibaldi, Gastroenterol Unit, Catania, Italy

[5] AOU Policlin Vittorio Emanuele, Internal Med Unit, Catania, Italy

[6] AOU Policlin Vittorio Emanuele, Gastroenterol Unit, Catania, Italy

[7] ARNAS Civ Cristina Benfratelli, Gastroenterol & Endoscopy Unit, Palermo, Italy

[8] AO Guzzardi, Gastroenterol Unit, Vittoria, Italy

[9] AOOR S Elia M Raimondi, Gastroenterol Unit, Caltanissetta, Italy

[10] AO Santa Marta & S Venera, Gastroenterol Unit, Acireale, Italy

[11] AO Umberto I, Surg Unit, Siracusa, Italy

[12] AO Giovanni Paolo II, Internal Med Unit, Sciacca, Italy

[13] AO S Antonio Abate, Gastroenterol & Endoscopy Unit, Trapani, Italy

[14] AOOR Papardo Piemonte, Gastroenterol Unit, Messina, Italy

[15] AO Buccheri La Ferla Fatebenefratelli, Gastroenterol & Endoscopy Unit, Palermo, Italy

[16] AOU Policlin G Martino, Genet & Pediat Immunol Unit, Messina, Italy

[17] AOU Policlin G Martino, Pediat Gastroenterol Unit, Messina, Italy

[18] AOOR Villa Sofia Cervello, Pediat Unit, Palermo, Italy

[19] AOU Policlin G Giaccone, Pediat Unit, Palermo, Italy

[20] AO Cannizzaro, Gastroenterol Unit, Catania, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2017年 / 49卷

关键词：

D O I：

10.1016/S1590-8658(17)30329-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OC.06.2

引用

页码：E91 / E91

页数：1

共 50 条

[21] Safety of sequential biological therapy in inflammatory bowel disease: results from a tertiary referral Centre
Moens, Annick
Tabib, Nasim Sadat Seyed
Ballet, Vera
Sabino, Joao
Vermeire, Severine
Ferrante, Marc
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) : 271 - 281
[22] Assessment of the safety and efficacy of biological monotherapy versus dual therapy with immunosuppressants for the treatment of inflammatory bowel disease.
Wheat, C.
Lynema, S.
Ko, C.
Cullinan, C.
Etter, S.
Sinanan, M.
Lee, S.
INFLAMMATORY BOWEL DISEASES, 2011, 17 : S65 - S65
[23] Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: A prospective pilot study
Martin de Carpi, Javier
Vilar, Pere
Prieto, Gerardo
Garcia Novo, Maria Dolores
Ribes, Carmen
Varea, Vicente
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 46 (04): : 386 - 391
[24] GRANULOCYTOAPHERESIS IN INFLAMMATORY BOWEL DISEASE: SAFETY AND EFFICACY
Martin, Dominguez F.
Mingot, Castellano M. E.
Leo, E.
Escamilla, Gomez, V
Calderon, Cabrera C.
Perez-Simon, J. A.
HAEMATOLOGICA, 2020, 105 : 250 - 251
[25] THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): A COMPARISON OF THE EFFICACY OF CURRENT BIOLOGICS IN CROHN'S DISEASE
Orlando, A.
Macaluso, F. S.
Fries, W.
Privitera, A. C.
Cappello, M.
Siringo, S.
Inserra, G.
Magnano, A.
Di Mitri, R.
Belluardo, N.
Scarpulla, G.
Magri, G.
Trovatello, A.
Carroccio, A.
Genova, S.
Bertolami, C.
Vassallo, R.
Romano, C.
Pellegrino, S.
Citrano, M.
Accomando, S.
Ventimiglia, M.
Renna, S.
Orlando, R.
Rizzuto, G.
Ferracane, C.
Cottone, M.
DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E72 - E73
[26] Quality of life in inflammatory bowel disease(IBD): Preliminary data of a prospective multicenter Italian study.
Tatarella, M
Saibeni, S
Rivolta, R
Gerardo, S
Corbellini, A
Bortoli, A
Ferraris, L
Colombo, E
Alvisi, C
Imperiali, G
de Franchis, R
GASTROENTEROLOGY, 1999, 116 (04) : A100 - A100
[27] SURROGATE MARKERS OF ATHEROSCLEROSIS IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT OF SICILIAN PATIENTS
Cilluffo, M. G.
Scrivo, B.
Tuttolomondo, A.
Torres, D.
Pinto, A.
Camma, C.
Cappello, M.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E111 - E112
[28] Systematic review: the safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease
Dulai, P. S.
Gleeson, M. W.
Taylor, D.
Holubar, S. D.
Buckey, J. C.
Siegel, C. A.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) : 1266 - 1275
[29] Efficacy and Safety of Dual Therapy for Refractory Inflammatory Bowel Disease in a Danish Cohort
Haase, A. M.
Bendix, M.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1533 - i1534
[30] Meta-Analysis of the Efficacy and Safety of Bisphosphonate Therapy in Inflammatory Bowel Disease
Melek, John
Sakuraba, Atsushi
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S672 - S672

← 1 2 3 4 5 →